Munich news, health insurance, technology, jobs and other topics for expatriates. The Eye Newspapers covers daily news and offers services for foreigners.

A new large-scale study has mapped the first molecular events that drive the formation of harmful amyloid protein aggregates ...

Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) is one of the 13 Biotech Stocks with Huge Upside Potential. It declared on June 9 ...

As multiple companies vie to expand on Alnylam’s success in commercializing RNAi therapeutics, the pioneering company has set ...

Targeted Oncology connects oncology professionals with updates on immunotherapy, biomarkers, cancer pathways, and targeted ...

Scientists behind a world-first gene therapy reveal how they teamed up with experts across academia and industry to produce a ...

rb3.so-net.ne.jp Objective To elucidate the long-term effects of liver transplantation (LT) on familial amyloid polyneuropathy (FAP). Methods We investigated clinicopathological and biochemical ...

Shares of Intellia Therapeutics NTLA were down 22.9% yesterday after it announced an update from the ongoing phase III study, evaluating the investigational in vivo genome-editing candidate, nexiguran ...

Shares of Intellia Therapeutics (NASDAQ: NASDAQ:NTLA) plunged 19% following a safety update from its ongoing Phase 3 MAGNITUDE study. The clinical trial, which is evaluating the company’s gene-editing ...

Detailed price information for Immix Biopharma Inc (IMMX-Q) from The Globe and Mail including charting and trades.

Aside from liver transplantation, alternative therapeutic options have including TTR tetramer ... Lastly, utility of therapeutic approaches targeting specific pathophysiological mechanisms in ATTRv ...